- Home
- INGN vs VNDA Comparison
INGN vs VNDA Comparison
Compare INGN & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INGN
- VNDA
- Stock Information
- Founded
- INGN 2001
- VNDA 2002
- Country
- INGN United States
- VNDA United States
- Employees
- INGN N/A
- VNDA N/A
- Industry
- INGN Industrial Specialties
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- INGN Health Care
- VNDA Health Care
- Exchange
- INGN Nasdaq
- VNDA Nasdaq
- Market Cap
- INGN 219.3M
- VNDA 249.4M
- IPO Year
- INGN 2014
- VNDA 2006
- Fundamental
- Price
- INGN $8.53
- VNDA $5.54
- Analyst Decision
- INGN Strong Buy
- VNDA Strong Buy
- Analyst Count
- INGN 3
- VNDA 2
- Target Price
- INGN $11.00
- VNDA $16.50
- AVG Volume (30 Days)
- INGN 154.3K
- VNDA 551.1K
- Earning Date
- INGN 11-05-2025
- VNDA 10-29-2025
- Dividend Yield
- INGN N/A
- VNDA N/A
- EPS Growth
- INGN N/A
- VNDA N/A
- EPS
- INGN N/A
- VNDA N/A
- Revenue
- INGN $343,472,000.00
- VNDA $203,467,000.00
- Revenue This Year
- INGN $8.12
- VNDA $15.45
- Revenue Next Year
- INGN $9.02
- VNDA $37.82
- P/E Ratio
- INGN N/A
- VNDA N/A
- Revenue Growth
- INGN 5.15
- VNDA 11.78
- 52 Week Low
- INGN $5.70
- VNDA $3.81
- 52 Week High
- INGN $12.91
- VNDA $5.70
- Technical
- Relative Strength Index (RSI)
- INGN 51.84
- VNDA 66.36
- Support Level
- INGN $8.43
- VNDA $5.46
- Resistance Level
- INGN $9.13
- VNDA $5.70
- Average True Range (ATR)
- INGN 0.30
- VNDA 0.18
- MACD
- INGN -0.02
- VNDA 0.01
- Stochastic Oscillator
- INGN 50.41
- VNDA 81.36
About INGN Inogen Inc
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.